Antitumor anthraquinones from an endophytic actinomycete Micromonospora lupini sp. nov.

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 13, 2007, Pages 3702-3705

  Igarashi, Yasuhiro ^a   Trujillo, Martha E ^b   Martínez Molina, Eustoquio ^b   Yanase, Saeko ^a   Miyanaga, Satoshi ^a   Obata, Takamasa ^a   Sakurai, Hiroaki ^c   Saiki, Ikuo ^c   Fujita, Tsuyoshi ^d   Furumai, Tamotsu ^a  

^a TOYAMA PREFECTURAL UNIVERSITY   (Japan)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c UNIVERSITY OF TOYAMA   (Japan)

^d SUNTORY INSTITUTE FOR BIOORGANIC RESEARCH   (Japan)

Author keywords

Antitumor; Invasion; Lupinacidin; Micromonospora

Indexed keywords

1,3,6 TRIHYDROXY 8 N BUTYLANTHRAQUINONE; ANTHRACYCLINE DERIVATIVE; ANTHRAQUINONE DERIVATIVE; ANTINEOPLASTIC AGENT; LUPINACIDIN A; LUPINACIDIN B; TAMOXIFEN; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG;

ACTINOBACTERIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIUM CULTURE; CARCINOMA CELL; CELL GROWTH; CELL INVASION; COLON CARCINOMA; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ENDOPHYTE; HUMAN; HUMAN CELL; MICROMONOSPORA LUPINI;

ANIMALS; ANTHRAQUINONES; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMISTRY, PHARMACEUTICAL; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; INHIBITORY CONCENTRATION 50; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICROMONOSPORA; MODELS, CHEMICAL; MOLECULAR CONFORMATION;

MICROMONOSPORA; MURINAE;

EID: 34250176599     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.04.039     Document Type: Article

References (18)

1. Bioactive microbial metabolites Part 31. Part 30:. Miyanaga S., Obata T., Onaka H., Fujita T., Saito N., Sakurai H., Saiki I., Furumai T., and Igarashi Y. J. Antibiot. 59 (2006) 698
2. Liotta L.A., and Stetler-Stevenson W.G. Cancer Res. 51 (1991) 5054
3. Kohn E.C., and Liotta L.A. Cancer Res. 51 (1995) 1856
4. Woodhouse E.C., Chuaqui R.F., and Liotta L.A. Cancer 80 (1997) 1529
5. Geho D.H., Bandle R.W., Clair T., and Liotta L.A. Physiology 20 (2005) 194
6. 14 At the end of the fermentation period, 50 ml of 1-butanol was added to each flask, and they were allowed to shake for 1 additional hour. The mixture was centrifuged at 2000 rpm for 15 min and the organic layer was separated from the aqueous layer containing the mycelium. Evaporation of the extraction solvent in vacuo provided approximately 2.88 g of extract per 1 L of culture.
7. Saito K.I., Oku T., Ata N., Miyashiro H., Hattori M., and Saiki I. Biol. Pharm. Bull. 20 (1997) 345
8. 4 buffer solution to afford 1 (38.4 mg) and 2 (9.9 mg).
9. 5 341.1388, -0.3 mmu).
10. Umezawa, H., Eds. Index of Antibiotics From Actinomycetes; Japan Scientific Societies Press: Tokyo, 1978; Vol. II.
11. 5, 327.1227, +0.1 mmu).
12. Hori Y., Abe Y., Nishimura M., Goto T., Okuhara M., and Kohsaka M. J. Antibiot. 46 (1993) 1069
13. Che J., and Thompson L.U. Breast Cancer Res. Treat. 80 (2003) 163
14. Ishida H., Wada K., Masuda T., Okura M., Kohama K., Sano Y., Nakajima A., Kogo M., and Kamisaki Y. Cancer Sci 98 (2007) 636
15. Benbow U., Maitra R., Hamilton J.W., and Brinckerhoff C.E. Clin. Cancer Res. 5 (1999) 203
16. Addadi-Rebbah S., Poitevin S., Fourre N., Polette M., Garnotel R., and Jeannesson P. Int. J. Oncol. 24 (2004) 1607
17. Acharya M.R., Venitz J., Figg W.D., and Sparreboom A. Drug Resist. Updat. 7 (2004) 195
18. Igarashi Y., Iida T., Yoshida R., and Furumai T. J. Antibiot. 55 (2002) 764